# Biomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitors

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/biomarkers-of-response-and-resistance-to-pi3k-inhibitors-in-estrogen-receptor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Mariana Brandão,Rafael Caparica,Daniel Eiger,Evandro de Azambuja |
| Citations | 98 |
| DOI | 10.1093/annonc/mdz280 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.annalsofoncology.org/article/S0923753420343726/pdf |
| OpenAlex ID | https://openalex.org/W2996689167 |
| PMID | 31859350 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Mariana Brandão](https://scholariq.org/researchers/mariana-brandao/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Paper topics

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.